FIELD: chemistry.
SUBSTANCE: invention describes novel macrocyclic compounds of formulae pharmaceutically acceptable salts or stereoisomers thereof, where R1 = -OR5, -NH-SO2R6; R2 = hydrogen; R3 = C1-6-alkyl; R4 = isoquinolinyl, possibly substituted; n equals 4 or 5; R5 = hydrogen; R6 = C3-7-cycloalkyl, and a pharmaceutical composition containing said compounds.
EFFECT: novel compounds have hepatitis C virus replication inhibitory action and can be used in medicine.
6 cl, 32 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | 2006 |
|
RU2441870C2 |
HEPATITIS C VIRUS MACROCYCLIC INHIBITORS | 2006 |
|
RU2486189C2 |
MACROCYCLIC INDOLE DERIVATIVES, APPLICABLE AS INHIBITORS OF HEPATITIS C VIRUS | 2009 |
|
RU2518471C2 |
MACROCYCLIC PHENYLCARBAMATES INHIBITING HCV | 2008 |
|
RU2490261C2 |
HETEROCYCLIC COMPOUNDS AND USE THEREOF FOR PREVENTING OR TREATING BACTERIAL INFECTIONS | 2016 |
|
RU2714197C2 |
BENZOTHIAZINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAL DRUGS | 2010 |
|
RU2523791C2 |
BRIDGED N-CYCLYC SULPHONAMIDO-INHIBITORS OF GAMMA-SECRETASE | 2006 |
|
RU2422443C2 |
MACROCYCLIC PEPTIDES ELICITING ACTIVITY WITH RESPECT TO HEPATITIS C VIRUS | 2000 |
|
RU2247126C2 |
MACROCYCLIC HEPATITIS TYPE C VIRUS INHIBITORS | 2006 |
|
RU2419619C2 |
ANTIRETROVIRAL COMPOUNDS AND USE THEREOF | 2010 |
|
RU2571662C2 |
Authors
Dates
2011-12-27—Published
2006-07-28—Filed